Feverfew as preventive therapy for migraine: N-of-1-trial for verification of individual efficacy;Mutterkraut als prophylaktische phytotherapie bei migräne: N-of-1-studie zum individuellen wirksamkeitsnachweis

Zeitschrift fur Allgemeinmedizin

Volumn 83, Issue 6, 2007, Pages 238-241

  Trader J M ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Feverfew; Migraine; N of 1 trial; Practice trial; Prophylaxis

Indexed keywords

LACTOSE; TANACETUM PARTHENIUM EXTRACT;

ARTICLE; CHRYSANTHEMUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; MIGRAINE;

EID: 34447320734     PISSN: 09376801     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-977710     Document Type: Article

References (12)

1. Guyatt G, Sackett D, Adachi J, et al. A clinician's guide for conducting randomized trials in individual patients. Can Med Ass J 1988; 139: 497-503
2. Therapie der Migräneattacke und Migräneprophylaxe Empfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft (DMKG) in Kooperation mit der Kommission "Schmerztherapie" der deutschen Gesellschaft für Neurologie (DGN). http://www.dmkg.de
3. Vogler BK, Pittler MH, Ernst E. Feverfew as a preventive treatment for migraine: a systematic review. Cephalgia 1998; 18: 704-708
4. Pittler MH, Ernst E. Feverfew for preventing migraine (Cochrane Review). The Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No. CD002286
5. Göbel H. Kieler Kopfschmerzkalender. http://www. schmerzklinik.de/ Kieler_Kopfschmerzkalender.pdf
6. Johnson ES, Kadam NP, Hylands DM, et al. Efficiacy of feverfew as prophlactic treatment of migraine. Br Med J 1985; 290: 569-573
7. Murphy JJ, Heptinstall S, Mitchell JR. Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet 1988; 1: 189-192
8. Pfaffenrath V, Diener HC, Fischer M, et al. The efficiacy and safety of Tanacetum parthenicum (feverfew) in migraine prophylaxis - a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalgia 2002; 20: 523-532
9. Diener HC, Pfaffenrath V, Schnitker J, et al. The efficiacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG 99) in migraine prevention - a randomized, double-blind, multicentre, placebo-controlled study. Cephalgia 2005; 23: 1031-1041
10. Shrivastava R, Pechadre LC, John GW. Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study. Clin Drug Investig. 2006; 11: 287-296
11. Yao M, Ritchie HE, Brown-Woodman PD. A reproductive screening test of feverfew: is a full reproductive study warranted? Reprod Toxicol 2006; 19: 688-693
12. Leitlinie Migräne der Deutschen Gesellschaft für Neurologie http://www.dgn.org/970.html